Click here to enlarge.
PDB ID:
Entry in NMR Restraints Grid
Validation report in NRG-CING
Chem Shift validation: AVS_anomalous, AVS_full, SPARTA
BMRB Entry DOI: doi:10.13018/BMR25489
MolProbity Validation Chart
NMR-STAR file interactive viewer.
NMR-STAR v3 text file.
XML gzip file.
RDF gzip file.
All files associated with the entry
Citation: Prior, Stephen; Fulcher, Yan; Koppisetti, Rama; Jurkevich, A.; Van Doren, Steven. "Charge-Triggered Membrane Insertion of Matrix Metalloproteinase-7, Supporter of Innate Immunity and Tumors" Structure 23, 2099-2110 (2015).
PubMed: 26439767
Assembly members:
proMMP-7(E195A), polymer, 248 residues, 27702.492 Da.
CALCIUM ION, non-polymer, 40.078 Da.
ZINC ION, non-polymer, 65.409 Da.
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE, non-polymer, 678.940 Da.
CHOLEST-5-EN-3-YL HYDROGEN SULFATE, non-polymer, 466.717 Da.
Natural source: Common Name: Human Taxonomy ID: 9606 Superkingdom: Eukaryota Kingdom: Metazoa Genus/species: Homo sapiens
Experimental source: Production method: recombinant technology Host organism: Escherichia coli Vector: pET28-a
Entity Sequences (FASTA):
proMMP-7(E195A): LPQEAGGMSELQWEQAQDYL
KRFYLYDSETKNANSLEAKL
KEMQKFFGLPITGMLNSRVI
EIMQKPRCGVPDVAEYSLFP
NSPKWTSKVVTYRIVSYTRD
LPHITVDRLVSKALNMWGKE
IPLHFRKVVWGTADIMIGFA
RGAHGDSYPFDGPGNTLAHA
FAPGTGLGGDAHFDEDERWT
DGSSLGINFLYAATHALGHS
LGMGHSSDPNAVMYPTYGNG
DPQNFKLSQDDIKGIQKLYG
KRSNSRKK
Data type | Count |
13C chemical shifts | 62 |
15N chemical shifts | 224 |
1H chemical shifts | 1223 |
Entity Assembly ID | Entity Name | Entity ID |
---|---|---|
1 | entity_1 | 1 |
2 | entity_CA | 2 |
3 | entity_ZN | 3 |
4 | entity_PX4 | 4 |
5 | entity_C3S | 5 |
Entity 1, entity_1 248 residues - 27702.492 Da.
1 | LEU | PRO | GLN | GLU | ALA | GLY | GLY | MET | SER | GLU | ||||
2 | LEU | GLN | TRP | GLU | GLN | ALA | GLN | ASP | TYR | LEU | ||||
3 | LYS | ARG | PHE | TYR | LEU | TYR | ASP | SER | GLU | THR | ||||
4 | LYS | ASN | ALA | ASN | SER | LEU | GLU | ALA | LYS | LEU | ||||
5 | LYS | GLU | MET | GLN | LYS | PHE | PHE | GLY | LEU | PRO | ||||
6 | ILE | THR | GLY | MET | LEU | ASN | SER | ARG | VAL | ILE | ||||
7 | GLU | ILE | MET | GLN | LYS | PRO | ARG | CYS | GLY | VAL | ||||
8 | PRO | ASP | VAL | ALA | GLU | TYR | SER | LEU | PHE | PRO | ||||
9 | ASN | SER | PRO | LYS | TRP | THR | SER | LYS | VAL | VAL | ||||
10 | THR | TYR | ARG | ILE | VAL | SER | TYR | THR | ARG | ASP | ||||
11 | LEU | PRO | HIS | ILE | THR | VAL | ASP | ARG | LEU | VAL | ||||
12 | SER | LYS | ALA | LEU | ASN | MET | TRP | GLY | LYS | GLU | ||||
13 | ILE | PRO | LEU | HIS | PHE | ARG | LYS | VAL | VAL | TRP | ||||
14 | GLY | THR | ALA | ASP | ILE | MET | ILE | GLY | PHE | ALA | ||||
15 | ARG | GLY | ALA | HIS | GLY | ASP | SER | TYR | PRO | PHE | ||||
16 | ASP | GLY | PRO | GLY | ASN | THR | LEU | ALA | HIS | ALA | ||||
17 | PHE | ALA | PRO | GLY | THR | GLY | LEU | GLY | GLY | ASP | ||||
18 | ALA | HIS | PHE | ASP | GLU | ASP | GLU | ARG | TRP | THR | ||||
19 | ASP | GLY | SER | SER | LEU | GLY | ILE | ASN | PHE | LEU | ||||
20 | TYR | ALA | ALA | THR | HIS | ALA | LEU | GLY | HIS | SER | ||||
21 | LEU | GLY | MET | GLY | HIS | SER | SER | ASP | PRO | ASN | ||||
22 | ALA | VAL | MET | TYR | PRO | THR | TYR | GLY | ASN | GLY | ||||
23 | ASP | PRO | GLN | ASN | PHE | LYS | LEU | SER | GLN | ASP | ||||
24 | ASP | ILE | LYS | GLY | ILE | GLN | LYS | LEU | TYR | GLY | ||||
25 | LYS | ARG | SER | ASN | SER | ARG | LYS | LYS |
Entity 2, entity_CA - Ca - 40.078 Da.
1 | CA |
Entity 3, entity_ZN - Zn - 65.409 Da.
1 | ZN |
Entity 4, entity_PX4 - C36 H73 N O8 P - 678.940 Da.
1 | PX4 |
Entity 5, entity_C3S - C27 H46 O4 S - 466.717 Da.
1 | C3S |
NOE: entity_1, [U-100% 15N, U-100% 13CH3 (ILV)], 0.4 mM; 1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE 50 mM; 1,2-DIHEXANEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE 100 mM; CHOLEST-5-EN-3-YL HYDROGEN SULFATE 3 mM; imidazole 20 mM; CaCl2 10 mM; ZnCl2 20 uM; beta-mercaptoethanol 10 mM; sodium azide 0.02%; H2O 90%; D2O 10%
PRE: entity_1, [U-100% 15N, U-100% 13CH3 (ILV)], 0.4 mM; entity_PX4 50 mM; entity_PX4 100 mM; entity_C3S 3 mM; imidazole 20 mM; CaCl2 10 mM; ZnCl2 20 uM; beta-mercaptoethanol 10 mM; sodium azide 0.02%; 1-palmitoyl-2-stearoyl-(14-doxyl)-sn-glycero-3-phosphocholine 1.5 mM; 1,2-dipalmitoyl-sn-glycero-3-phospho(tempo)choline 1.5 mM; H2O 90%; D2O 10%
sample_conditions_1: pH: 6.6; temperature: 310 K
Name | Sample | Sample state | Sample conditions |
---|---|---|---|
3D 1H-15N NOESY | NOE | isotropic | sample_conditions_1 |
3D 1H-13C NOESY | NOE | isotropic | sample_conditions_1 |
2D 1H-15N HSQC, CPMG | PRE | isotropic | sample_conditions_1 |
2D 1H-13C HSQC, CPMG | PRE | isotropic | sample_conditions_1 |
TOPSPIN v3.1, Bruker Biospin - collection, processing
Analysis v2.4, CCPN - chemical shift assignment, peak picking
HADDOCK v2.1, Alexandre Bonvin - structure solution
GROMOS v4.5.7, van Gunsteren and Berendsen - refinement
NCBI | NP_002414.1 |
Download HSQC peak lists in one of the following formats:
CSV: Backbone
or all simulated peaks
SPARKY: Backbone
or all simulated peaks